Center for Cancer Nanotechnology Excellence Focused on Therapy Response

2009 Annual CCNE-TR Symposium

Bechtel Conference Center, Encina Hall, 616 Serra Street, Stanford University
May 28 - 29, 2009

Registration is required and free. Register Online: https://med.stanford.edu/survey/CCNE_Symposium
Symposium Brochure: Download Brochure
Poster Submission Instructions: Download Instructions
Transportation To/From Symposium: Shuttle Service To and From Galvez Parking Lot | From Stanford Terrace Inn

Symposium Overview
The symposium will feature world-renowned thought leaders, scientists, engineers, and clinicians as panel speakers on a variety of frontier cancer nanotechnology subject matters. Additional presentations from CCNE-TR members will also highlight cancer nanotechnology activities in the NCI-funded CCNE-TR programs. There will be a poster session and submissions are encouraged from all researchers with nanomedicine interests. This symposium will be an excellent opportunity for exchange of ideas and creation of an environment for interdisciplinary collaborative work with fellow researchers. This two-day symposium is free and will be held on May 28-29, 2009 at the Bechtel Conference Center at Encina Hall at Stanford University. Early registrations are encouraged due to space limitations. With your input, we are looking forward to having stimulating discussions on frontier Diagnostic and Therapeutic Cancer Nanotechnologies.

Plenary and Keynote Speakers

Arden Bement, Jr., Ph.D.
Director, National Science Foundation

Anna D. Barker, Ph.D.
Deputy Director of National Cancer Institute &
Deputy Director for Strategic Scientific Initiatives

Janet Woodcock, M.D., Ph.D.
Director, Center for Drug Evaluation and Research
Food and Drug Administration

Roger Kornberg, Ph.D.
Professor, Structural Biology, Stanford University
2006 Chemistry Nobel Laureate

Other Distinguished Speakers

David Agus, M.D.
Professor, Medicine
Keck School of Medicine, University of Southern California

Demir Akin, D.V.M., Ph.D.
Deputy Director, CCNE-TR
School of Medicine, Stanford University

Paul Alivisatos, Ph.D.
Interim Director of Lawrence Berkeley National Laboratory
Professor of Nanotechnology, University of California, Berkeley

Jennifer R. Cochran Ph.D.
Assistant Professor, Bioengineering, Stanford University

Andrew Ellington, Ph.D.
Professor, Chemistry and Biochemistry, University of Texas at Austin

Dean Felsher, M.D., Ph.D.
Associate Professor, Medicine - Oncology and Pathology, Stanford University

Sanjiv Sam Gambhir, M.D., Ph.D.
Director, Molecular Imaging Program at Stanford
Professor, Radiology and Bioengineering
Stanford University

Robert H. Getzenberg, Ph.D.
Research Director
Professor, Urology Research
Johns Hopkins Medicine

Samir Hanash, M.D., Ph.D.
Program Head, Molecular Diagnostics Program
Fred Hutchinson Cancer Research Center

Martin McIntosh, Ph.D.
Director, Computational Proteomics Laboratory
Fred Hutchinson Cancer Research Center

Garry Nolan, Ph.D.
Associate Professor, Microbiology and Immunology
Director, Stanford NHLBI Proteomics Center
Stanford University

David R. Parkinson, M.D.
President and CEO
Nodality

Christine Peterson
Vice President
Foresight Institute

Shan Wang, Ph.D.
Professor, Materials Science & Engineering
Stanford University

Anna Wu, Ph.D.
Professor, Molecular & Medical Pharmacology
Assoc. Director, Crump Institute for Molecular Imaging, University of California, Los Angeles